Skip to main content

Table 3 Amino acid sequence variants of the 115-amino-acid region of the E protein isolated from human plasma (A–G) and mosquito (a–h) samples compared with their corresponding master sequences (B and a)

From: Genomic studies of envelope gene sequences from mosquito and human samples from Bangkok, Thailand

Sequence variant

No. of clones (% of total)

Clones

No. of amino acid substitutionsa

Type of amino acid substitutionb

A

1 (1.8)

36-2

1

I339M

B

23 (42)

36-3, 4, 6, 8, 9, 10, 11, 12

45-1, 5, 6, 14, 25

47-1, 2, 3, 4, 5, 6, 7, 8, 9, 10

0

–

C

1 (1.8)

36-14

1

Q316R

D

19 (34.5)

37-1, 2, 3, 4, 5, 6, 8, 10, 16, 18

41-2, 4, 9, 18, 23, 24, 26, 27, 28

1

H346Y

E

1 (1.8)

45-15

1

D329G

F

9 (16.4)

50-2, 3, 4, 5, 6, 7, 8, 9, 10

2

G318R, R350S

G

1 (1.8)

50-1

3

D290G, G318R, R350S

Total

55

 

9

 

a

13

56-4, 7, 15

275-24, 25, 27, 30, 32, 33, 35, 36, 37, 38

0

–

b

1

56-20

1

I335T

c

1

275-26

1

N276Y

d

1

275-31

2

N276T, P372L

e

1

275-39

1

K361E

f

1

275-40

1

M297I

g

9

56-2, 5, 6, 8, 10, 12, 13, 14, 17

1

H346Y

h

1

56-3

2

F279S, H346Y

Total

28

 

9

 
  1. aNumber of substitutions relative to master sequences B and a
  2. bI, isoleucine; T, threonine; N, asparagine; Y, tyrosine; P, proline; L, leucine; K, lysine; E, glutamic acid; M, methionine; H, histidine; F, phenylalanine, S, serine; Q, glutamic acid; R, arginine; D, aspartic acid; G, glycine